Nazar Trotsko

Lublin, LU, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.

Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.

Journal: Frontiers in immunology

Published: December 16, 2025

Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.

Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.

Journal: International journal of molecular sciences

Published: September 06, 2025

Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021-Present).

Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021-Present).

Journal: Molecules (Basel, Switzerland)

Published: April 23, 2025

The new thiazolidine-2,4-dione-based hybrids with promising antimycobacterial activity: design, synthesis, biological evaluation, and drug interaction analysis.

The new thiazolidine-2,4-dione-based hybrids with promising antimycobacterial activity: design, synthesis, biological evaluation, and drug interaction analysis.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 03, 2025

Efficient Method of (S)-Nicotine Synthesis.

Efficient Method of (S)-Nicotine Synthesis.

Journal: Molecules (Basel, Switzerland)

Published: October 22, 2024

Rhodanine-Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer Agents.

Rhodanine-Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer Agents.

Journal: International journal of molecular sciences

Published: October 13, 2024

Thiazolidin-4-Ones as a Promising Scaffold in the Development of Antibiofilm Agents-A Review.

Thiazolidin-4-Ones as a Promising Scaffold in the Development of Antibiofilm Agents-A Review.

Journal: International journal of molecular sciences

Published: November 26, 2023

Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione-Thiosemicarbazone Hybrid Molecules.

Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione-Thiosemicarbazone Hybrid Molecules.

Journal: International journal of molecular sciences

Published: October 31, 2023

TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents.

TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents.

Journal: International journal of molecular sciences

Published: December 05, 2022

Thiazolidin-4-one-based derivatives - Efficient tools for designing antiprotozoal agents. A review of the last decade.

Thiazolidin-4-one-based derivatives - Efficient tools for designing antiprotozoal agents. A review of the last decade.

Journal: Bioorganic chemistry

Published: November 10, 2022

Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.

Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: September 27, 2022

Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.

Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.

Journal: Molecules (Basel, Switzerland)

Published: March 28, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026